Eli Lilly And Company | Patient Daily

Eli Lilly And Company

Carol Ostrow | Oct 14, 2017

Lilly wins right to patent Alimta vitamin treatment for certain lung cancers

Carrie Bradon | Sep 21, 2017

Oncology Data Network called key to improving health care in Europe

Carol Ostrow | Sep 20, 2017

Lilly study supports Cyramza (ramucirumab) efficacy for treating urothelial carcinoma

Carrie Bradon | Jul 9, 2017

Japanese Ministry of Health, Labor and Welfare approves Olumiant

Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days

Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease

Robert Hadley | Jun 14, 2017

Eli Lilly anti-cancer drug may halt breast cancer spread when paired with fulvestrant

Ruth de Jauregui | May 21, 2017

Lilly says studies show galcanezumab can reduce migraine episodes

Trending

Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'

+ Pharmaceuticals

Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'

+ Pharmaceuticals

Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program